
Biopharma IPOs showed signs of recovery in 2024
Biopharmaceutical initial public offerings (IPOs) saw an upturn in 2024, with 50 completed IPOs raising a total of $8.52 billion – a 1.6-fold increase from the $5.06 billion raised in 2023. As such, 2024 had the highest total IPO value raised since 2021, …